$70.91 +0.26 (0.368%) Eli Lilly & Co - NYSE

Mar. 5, 2015 | 11:30 AM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
1/25/2013Walsh Fionnuala MSVP, Global Quality3,881$53.2179.40%
1/25/2013Tapiero JacquesSVP&Pres., Emerging Markets19,733$53.2174.18%
1/25/2013Ricks David ASVP and Pres, Lilly Bio-Meds11,174$53.2159.54%
1/25/2013Peterson Barton RSr. VP, Corp. Affairs & Comm.16,165$53.21112.23%
1/25/2013Simmons Jeffrey NSVP&Pres.,Elanco Animal Health19,735$53.2172.60%
1/25/2013Mahony SusanSVP & Pres., Lilly Oncology24,594$53.21119.27%
1/25/2013Mahony SusanSVP & Pres., Lilly Oncology1,657$53.2136.33%
1/25/2013Harrington Michael JSenior VP and General Counsel5,639$53.2136.22%
1/25/2013Fry Stephen FSVP, HR & Diversity5,124$53.2123.67%
1/25/2013Crowe Maria APresident, Mfg. Operations13,459$53.21125.56%
1/25/2013Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM1,367$53.21204.95%
1/25/2013Zakrowski Donald AChief Accounting Officer1,300$53.21115.66%
1/25/2013LECHLEITER JOHN CChairman, President, and CEO129,075$53.2148.20%
1/25/2013Conterno Enrique ASr. VP & Pres., Lilly Diabetes33,017$53.21122.23%
1/25/2013Lundberg Jan MEVP,Science&Tech and Pres. LRL44,832$53.21134.44%
12/03/2012Zakrowski Donald AChief Accounting Officer-517$49.04-31.51%
12/03/2012Fry Stephen FSVP, HR & Diversity-1,166$49.04-5.11%
12/03/2012Ricks David ASVP and Pres, Lilly Bio-Meds-865$49.04-4.41%
11/30/2012Alvarez RalphDirector3,083$47.0323.10%
11/30/2012BISCHOFF WINFRIED F W SIRDirector3,083$47.038.77%
11/30/2012ESKEW MICHAEL LDirector3,083$47.0316.35%
11/30/2012Fyrwald J ErikDirector3,083$47.038.35%
11/30/2012GILMAN ALFRED GDirector3,083$47.037.57%
11/30/2012HOOVER R DAVIDDirector3,083$47.0316.75%
11/30/2012HORN KAREN NDirector3,083$47.035.41%
11/30/2012MARRAM ELLEN RDirector3,083$47.039.61%
11/30/2012OBERHELMAN DOUGLAS RDirector3,083$47.0323.10%
11/30/2012PRENDERGAST FRANKLYN GDirector3,083$47.036.43%
11/30/2012SEIFERT KATHI PDirector3,083$47.036.64%
10/01/2012Tapiero JacquesSVP&Pres., Emerging Markets-4,643$47.41-14.86%
8/01/2012Conterno Enrique ASr. VP & Pres., Lilly Diabetes-5,000$44.16-15.62%
6/14/2012Tapiero JacquesSVP&Pres., Emerging Markets-2,125$41.60-10.18%
6/01/2012Conterno Enrique ASr. VP & Pres., Lilly Diabetes-5,000$40.60-11.90%
5/18/2012HANISH ARNOLD CChief Accounting Officer-1,295$40.49-6.80%
5/14/2012Tapiero JacquesSVP&Pres., Emerging Markets-2,000$41.04-8.75%
5/01/2012Conterno Enrique ASr. VP & Pres., Lilly Diabetes-5,000$41.32-10.64%
4/17/2012Tapiero JacquesSVP&Pres., Emerging Markets-2,000$40.00-8.04%
4/02/2012Conterno Enrique ASr. VP & Pres., Lilly Diabetes-5,000$40.30-9.61%
3/12/2012Tapiero JacquesSVP&Pres., Emerging Markets-2,000$39.60-7.44%
2/13/2012Simmons Jeffrey NSVP&Pres.,Elanco Animal Health-7,900$38.85-22.52%
2/02/2012Rice Derica WEVP-Global Services and CFO-3,800$39.61-6.33%
2/01/2012Lundberg Jan MEVP,Science&Tech and Pres. LRL-11,338$39.74-25.37%
2/01/2012Peterson Barton RSr. VP, Corp. Affairs & Comm.-5,252$39.74-25.39%
2/01/2012Deane Frank MPresident, Mfg. Operations-15,497$39.74-31.31%
2/01/2012Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-36,463$39.74-26.21%
2/01/2012LECHLEITER JOHN CChairman, President, and CEO-91,157$39.74-19.92%
2/01/2012ARMITAGE ROBERT ASr. VP and General Counsel-24,309$39.74-20.03%
2/01/2012Rice Derica WEVP-Global Services and CFO-35,917$39.74-31.65%
2/01/2012Rice Derica WEVP-Global Services and CFO-17,584$39.85-22.67%
1/26/2012Mahony SusanSVP & Pres., Lilly Oncology1,285$39.4439.22%
1/26/2012Walsh Fionnuala MSVP, Global Quality11,883$39.44216.05%
1/26/2012HANISH ARNOLD CChief Accounting Officer2,235$39.4413.11%
1/26/2012Walsh Fionnuala MSVP, Global Quality11,884$39.44216.07%
1/26/2012Walsh Fionnuala MSVP, Global Quality3,600$39.44279.50%
1/26/2012Tapiero JacquesSVP&Pres., Emerging Markets5,237$39.4424.21%
1/26/2012Simmons Jeffrey NSVP&Pres.,Elanco Animal Health4,686$39.4415.42%
1/26/2012Ricks David ASVP and Pres, Lilly Bio-Meds6,948$39.4469.93%
1/26/2012Nobles AnneChief Eth/Cmpl Ofcr & SVP, ERM3,843$39.4419.51%
1/26/2012Mahony SusanSVP & Pres., Lilly Oncology1,203$39.4436.72%
1/26/2012Mahony SusanSVP & Pres., Lilly Oncology3,077$39.4411.17%
1/26/2012LECHLEITER JOHN CChairman, President, and CEO59,601$39.4433.43%
1/26/2012Fry Stephen FSVP, HR & Diversity5,962$39.4445.61%
1/26/2012Conterno Enrique ASr. VP & Pres., Lilly Diabetes7,117$39.4415.85%
1/26/2012ARMITAGE ROBERT ASr. VP and General Counsel17,709$39.4439.31%
1/26/2012HANISH ARNOLD CChief Accounting Officer2,210$39.4412.97%
12/30/2011HOOVER R DAVIDDirector248$40.741.41%
12/12/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,787$39.10-10.14%
11/30/2011OBERHELMAN DOUGLAS RDirector3,990$36.3445.34%
11/30/2011SEIFERT KATHI PDirector3,990$36.349.85%
11/30/2011HOOVER R DAVIDDirector319$36.342.44%
11/30/2011HOOVER R DAVIDDirector3,990$36.3429.79%
11/30/2011PRENDERGAST FRANKLYN GDirector3,990$36.349.54%
11/30/2011GILMAN ALFRED GDirector3,990$36.3411.42%
11/30/2011MARRAM ELLEN RDirector3,990$36.3414.92%
11/30/2011Alvarez RalphDirector3,990$36.3445.34%
11/30/2011BISCHOFF WINFRIED F W SIRDirector3,990$36.3413.42%
11/30/2011FELDSTEIN MARTIN SDirector3,990$36.3414.92%
11/30/2011ESKEW MICHAEL LDirector3,990$36.3428.37%
11/30/2011HORN KAREN NDirector3,990$36.347.90%
11/30/2011Fyrwald J ErikDirector3,990$36.3412.74%
11/18/2011Tapiero JacquesSVP&Pres., Emerging Markets-5,000$36.88-18.84%
11/11/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$37.55-9.08%
10/31/2011HOOVER R DAVIDDirector226$37.971.76%
10/31/2011HOOVER R DAVIDDirector224$38.291.74%
10/11/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$38.10-8.33%
10/02/2011Walsh Fionnuala MSVP, Global Quality-592$36.97-31.49%
10/01/2011Tapiero JacquesSVP&Pres., Emerging Markets-5,107$36.97-16.14%
9/30/2011HOOVER R DAVIDDirector229$37.521.81%
9/30/2011HOOVER R DAVIDDirector227$37.811.80%
9/12/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$35.91-7.69%
8/31/2011Simmons Jeffrey NSVP&Pres.,Elanco Animal Health-1,340$37.17-4.94%
8/31/2011HOOVER R DAVIDDirector240$35.771.96%
8/11/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$33.94-7.13%
7/29/2011HOOVER R DAVIDDirector226$38.051.88%
7/11/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$37.39-6.65%
7/06/2011Deane Frank MPresident, Mfg. Operations-5,000$37.20-29.20%
6/30/2011HOOVER R DAVIDDirector229$37.561.95%
6/27/2011Deane Frank MPresident, Mfg. Operations-3,300$36.73-16.16%
6/27/2011Deane Frank MPresident, Mfg. Operations-1,700$36.74-7.68%
6/20/2011Deane Frank MPresident, Mfg. Operations-5,000$37.38-18.43%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (LLY), click here.
  • Showing 201-300 of 339 items
  • <<
  • ...
  • 2
  • 3
  • 4
  • >>
Trading Center